                         SEQUENCE LISTING

<110>  haemopep Pharma GmbH
 
<120>  Herstellung und Verwendung von hochreinem Hemoparatide (hPTH-1-37) fr die Behandlung von 
       von entzndlich-schuppenden Erkrankungen der Haut

<130>  093399WO

<160>  5     

<170>  PatentIn version 3.3

<210>  1
<211>  37
<212>  PRT
<213>  Artificial

<220>
<223>  synthetic

<400>  1

Ser Val Ser Glu Ile Gln Leu Met His Asn Leu Gly Lys His Leu Asn 
1               5                   10                  15      


Ser Met Glu Arg Val Glu Trp Leu Arg Lys Lys Leu Gln Asp Val His 
            20                  25                  30          


Asn Phe Val Ala Leu 
        35          


<210>  2
<211>  11
<212>  PRT
<213>  Artificial

<220>
<223>  synthetic

<400>  2

Ser Val Ser Glu Ile Gln Leu Met His Asn Leu 
1               5                   10      


<210>  3
<211>  26
<212>  PRT
<213>  Artificial

<220>
<223>  synthetic

<400>  3

Gly Lys His Leu Asn Ser Met Glu Arg Val Glu Trp Leu Arg Lys Lys 
1               5                   10                  15      


Leu Gln Asp Val His Asn Phe Val Ala Leu 
            20                  25      


<210>  4
<211>  12
<212>  PRT
<213>  Artificial

<220>
<223>  synthetic

<400>  4

Gly Lys His Leu Asn Ser Met Glu Arg Val Glu Trp 
1               5                   10          


<210>  5
<211>  14
<212>  PRT
<213>  Artificial

<220>
<223>  synthetic

<400>  5

Leu Arg Lys Lys Leu Gln Asp Val His Asn Phe Val Ala Leu 
1               5                   10                  


